Endosulfan ban in India has finally been achieved after much protest. Excel Crop Care is one company that has already made a provision of Rs 10 crore with respect to endosulfan. Ashwin Shroff, Chairman, joins CNBC-TV18 to talk about the quarterly results and the way ahead for the company.
Below is the verbatim transcript. Also watch the accompanying video Q: You have already made a provision of Rs 10 crore with respect to endosulfan. With the assumption that perhaps this is banned, how much of a provision or hit can you all take? Will this Rs 10 crore be enough?A: That is the provision we have made based on the current situation. As you know, the Supreme Court order is an interim order and within two months or so, a report will come out. Then it will clarify the picture further. Q: So is this Rs 10 crore which is equivalent to two months worth?
A: No, it is not like that. It is reasonable estimate, a quantification of what the issue is. This is mainly for the inventories that we carry and some of the incoming material that is there. Also read: Endosulfan ban will affect revenues: Excel Crop Q: If the ban holds, then, considering endosulfan makes up for 30-35% of your revenues, won
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
